Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$29.51 - $46.26 $1.65 Million - $2.59 Million
56,000 New
56,000 $2.59 Million
Q1 2022

May 17, 2022

SELL
$16.53 - $25.21 $719,055 - $1.1 Million
-43,500 Reduced 47.85%
47,400 $1.07 Million
Q4 2021

Feb 15, 2022

BUY
$17.1 - $23.34 $1.05 Million - $1.43 Million
61,200 Added 206.06%
90,900 $1.8 Million
Q3 2021

Nov 16, 2021

BUY
$19.68 - $22.53 $210,576 - $241,071
10,700 Added 56.32%
29,700 $584,000
Q2 2021

Aug 16, 2021

SELL
$19.97 - $24.43 $43,934 - $53,746
-2,200 Reduced 10.38%
19,000 $418,000
Q1 2021

May 18, 2021

SELL
$23.49 - $30.56 $1.06 Million - $1.38 Million
-45,000 Reduced 67.98%
21,200 $504,000
Q4 2020

Feb 17, 2021

SELL
$16.78 - $27.3 $350,702 - $570,570
-20,900 Reduced 24.0%
66,200 $1.73 Million
Q3 2020

Nov 17, 2020

SELL
$12.46 - $19.98 $604,310 - $969,030
-48,500 Reduced 35.77%
87,100 $1.52 Million
Q2 2020

Aug 17, 2020

BUY
$11.0 - $18.26 $1.38 Million - $2.28 Million
125,000 Added 1179.25%
135,600 $2.28 Million
Q2 2018

Aug 15, 2018

BUY
$15.3 - $19.69 $162,180 - $208,714
10,600 New
10,600 $167,000
Q1 2018

May 15, 2018

SELL
$14.59 - $25.5 $223,227 - $390,150
-15,300 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$15.77 - $20.72 $241,281 - $317,016
15,300
15,300 $276,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.92B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.